Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
15 Nov 2016
The Lancet Publishes First Head-to-Head Study of Cimzia® (certolizumab pegol) and Humira® (adalimumab) in Bio-Naïve Rheumatoid Arthritis Patients
Read More
14 Nov 2016
Results from Phase 3 Bridge study showed romosozumab significantly increased bone mineral density in men with Osteoporosis
Read More
11 Nov 2016
UCB’s anti-epileptic drug VIMPAT® (lacosamide) receives positive opinion by EU CHMP as monotherapy for patients with partial-onset seizures
Read More
11 Nov 2016
UCB showcases advancements in its late stage immunology portfolio through innovative research at 2016 ACR/ARHP Annual Meeting
Read More
7 Nov 2016
Transparency notifications
Read More
25 Oct 2016
UCB continues its growth path
Read More
21 Oct 2016
Transparency notification
Read More
7 Oct 2016
Transparency notification
Read More
3 Oct 2016
CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis
Read More
26 Sep 2016
UCB and Amgen announce U.S. FDA acceptance of biologics licence application for Romosozumab
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
36
Page
37
Page
38
Page
39
Current page
40
Page
41
Page
42
Page
43
Page
44
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss